Interest in epicardial adipose tissue (EAT) is growing rapidly, and research in this area
appeals to a broad, multidisciplinary audience. EAT is unique in its anatomy and …

Epicardial adipose tissue is a unique and multifaceted fat depot with local and systemic
effects. This tissue is distinguished from other visceral fat depots by a number of anatomical …

Epicardial adipose tissue is an unusual visceral fat depot with anatomical and functional
contiguity to the myocardium and coronary arteries. Under physiological conditions …

Sarcopenia, obesity and their coexistence, obese sarcopenia (OBSP) as well as
atherosclerosis-related cardio-vascular diseases (ACVDs), including chronic heart failure …

Nowadays, obesity is seriously increasing in most of the populations all over the world, and
is associated with the development and progression of high-mortality diseases such as type …

Background It is unknown whether canagliflozin, a selective sodium glucose co-transporter
2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with …

Background Current understanding of metabolic heart disease consists of a myriad of
different pathophysiological mechanisms. Epicardial adipose tissue (EAT) is increasingly …

Epicardial fat is the visceral fat depot of heart. It is a metabolically active organ with
anatomical and functional contiguity to the myocardium. A dichotomous role has been …

Adipokines are peptides that signal the functional status of adipose tissue to the brain and
other target organs. In adipose tissue dysfunction, adipokine secretion is altered, and this …

Objectives: This study investigated the effect of bariatric surgery (BS)–induced weight loss
on cardiac ectopic fat using 3T magnetic resonance imaging in morbid obesity. Background …